We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00558298
Recruitment Status : Completed
First Posted : November 14, 2007
Last Update Posted : May 17, 2011
Information provided by:
Janssen, LP

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : February 2005